Personalised Program for Women Treated for Hodgkin Disease (PROPER)

Institut Paoli-Calmettes

Status: Terminated

Conditions: Breast Cancer; Hodgkin Disease

Treatments: Procedure: intensive screening

Study type: Interventional

Funder types: Other

Identifiers

NCT01188915

PROPER/IPC 2010-001

Details and patient eligibility

About

After treatment for Hodgkin disease, secondary cancer, in particular breast cancer induced by treatment, are the first cause of death.

The investigators will estimate the risk to develop breast cancer in this population of women treated for hodgkin disease, and will propose women at high rish to participate in an intensive screening program based on an annual detection based on mammography, echography, and RMI.

Enrollment: 51 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• women > 18 years
• treated for Hodgkin disease
• signed informed consent
• high risk of breast cancer

Exclusion criteria

• patients unable to have a regular follow-up

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

51 participants in 1 patient group

intensive screening

Experimental group

Description:

annual breast cancer detection based on mammography, echography and RMI.

Treatment:

Procedure: intensive screening